Saint Alphonsus Regional Medical Center in Boise has been accredited as a Comprehensive Center for patients seeking surgical treatment for obesity and related conditions by the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), a joint Quality Program of the American College of Surgeons (ACS) and the American Society for Metabolic and Bariatric Surgery (ASMBS).

This national recognition formally acknowledges the hospital’s commitment to providing and supporting quality improvement and patient safety efforts for metabolic and bariatric surgery patients.

“There is a large team of healthcare professionals behind this achievement,” said Dr. Christopher Reising, MD, FACS, lead bariatric surgeon. “As we’ve seen with the current COVID-19 pandemic, underlying health issues, like obesity, can make patients more vulnerable to the coronavirus. Addressing these comorbidities through surgery can help lead to a longer and more fulfilling life for our patients.”

The MBSAQIP Standards, Optimal Resources for Metabolic and Bariatric Surgery, ensure that metabolic and bariatric patients receive multidisciplinary medical care, which improves patient outcomes and long-term success. MBSAQIP-Accredited centers offer preoperative and postoperative care designed specifically for patients with obesity.

Saint Alphonsus’ program is tasked with continuous review of surgical data as they continue improving the structure and outcomes expertise necessary to provide safe, efficacious, and high-quality care to all metabolic and bariatric patients.

To earn MBSAQIP Accreditation, Saint Alphonsus met essential criteria for staffing, training, facility infrastructure and patient care pathways, ensuring its ability to support patients with obesity. The center also participates in a national data registry that yields semiannual reports on the quality of its surgical outcomes and identifying opportunities for quality improvement. The MBSAQIP Standards, Optimal Resources for Metabolic and Bariatric Surgery, are published by the ACS and the ASMBS.

The Centers for Disease Control and Prevention (CDC) estimates about 93 million adults in the United States are affected by obesity and that number continues to increase. The disease of obesity increases the risks of morbidity and mortality because of the diseases and conditions that are commonly associated with it, such as type II diabetes, hypertension, cardiovascular disease, and cancer, among other health risks. Metabolic and bariatric surgery has proven to be effective in the reduction of comorbid conditions related to obesity.* The ACS and the ASMBS have developed accreditation standards for metabolic and bariatric surgery to assist patients with obesity in identifying centers that provide optimal patient care.

________________________

*Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery: A Systematic Review and Meta-analysis. JAMA. 2004;292(14):1724-1737. DOI:10.1001/jama.292.14.1724.